Having a range of Covid-19 vaccines available for people to use around the world will be essential to bringing the pandemic under control. Here’s why.
Preliminary data from phase III clinical trials has shown the Pfizer-BioNTech and Moderna Covid-19 vaccines to be more than 90% effective. So, how do they work, are they safe, and when will they be available?
As heads of state and international organisations meet at the Paris Peace Forum, we ask whether investing in treatments now could help end this crisis.
Vaccines, tests and treatments, alongside well-equipped health systems, are the solutions to bringing the Covid-19 pandemic under control. But this won’t happen without urgent investment.
Finding and delivering Covid-19 treatments worldwide requires global collaboration at an unprecedented scale. This is being done through the ACT-Accelerator Therapeutics Partnership.
Effective treatments, that are accessible to everyone who needs them, have to be part of the solution to the coronavirus pandemic – here's why.
We need a range of treatments to make Covid-19 preventable and treatable. Jeremy Farrar describes recent progress made by research and why more investment is needed.
Monoclonal antibodies, one of the most promising treatments for Covid-19, are usually expensive and not available worldwide. Lindsay Keir highlights what needs to be done to change that.
For more than 30 years, monoclonal antibodies have transformed the way we treat many diseases. Researchers think they are also one of the most promising treatments for Covid-19. Here's why.
Six months after lockdown was first announced in the UK, the country is seeing a rise in Covid-19 infections. Jeremy Farrar reflects on the measures we need to suppress transmission.
Wellcome launched COVID-Zero in April to mobilise urgent donations from businesses and philanthropists for Covid-19 research. As we draw the campaign to a close, Mark Henderson discusses what it has achieved.